Results of retransplantation for recurrent hepatitis C
Sasan Roayaie, Thomas D. Schiano, Swan N. Thung, Sukru H. Emre, Thomas M. Fishbein, Charles M. Miller, Myron E. Schwartz – 30 December 2003 – Retransplantation for recurrent hepatitis C virus (HCV) has been evaluated in small series. In this study, patients undergoing transplantation for HCV‐related cirrhosis with subsequent retransplantation more than 90 days for recurrent HCV (proven by pathologic examination of the explant and exclusion of other factors) were prospectively followed.